Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/AION stock hub

CSE/AION has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/AIONis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/AION

In the news

Latest news · CSE/AION

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-158.2

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/AION market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

147

Groups with data

Currency

CAD

Showing 147 of 147 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	5
Enterprise value	CAD 5.3M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA00905T1021
Last refreshed	2026-05-10
Market cap	CAD 2.5M
Price	CAD 0.01
Price currency	CAD
Rev Per Employee	294,581.2x
Sector	Healthcare
Sic	5159
Symbol	cse/AION

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-267.34%
EV Earnings	-0.79x
EV/Sales	3.59x
P/B ratio	-0.53x
P/S ratio	1.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-103.49%
EBITDA Margin	-101.43%
Gross margin	32.29%
Gross Profit	CAD 475,590
Gross Profit Growth	190.49%
Gross Profit Growth Q	7%
Gross Profit Growth3 Y	120.95%
Net Income	CAD -6.6M
Net Income Growth Quarters	1%
Pretax Margin	-451.18%
Profit Per Employee	CAD -1.3M
ROA	-26.86
Roa5y	-141.3
ROCE	32.62
ROIC	-158.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-66.69%
Cagr3y	-20.63%
Cagr5y	-45.08%
EPS Growth Quarters	1
Revenue Growth	563.34x
Revenue Growth Q	145.44x
Revenue Growth Quarters	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.42
Assets	CAD 1.2M
Cash	CAD 13,820
Current Assets	CAD 1.1M
Current Liabilities	CAD 5.9M
Debt	CAD 2.8M
Equity	CAD -4.7M
Interest Coverage	-4.6
Liabilities	CAD 5.9M
Long Term Assets	CAD 86,084
Long Term Liabilities	CAD -1
Net Cash	CAD -2.8M
Net Cash By Market Cap	CAD -112
Tangible Book Value	CAD -4.7M
Tangible Book Value Per Share	CAD -0.01
WACC	5.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.19
Inventory Turnover	2.47
Net Working Capital	CAD -2M
Quick ratio	0.03
Working Capital	CAD -4.8M
Working Capital Turnover	CAD -0.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-129.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-66.67%
200-day SMA	0.01
3Y total return	-50%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-95%
All Time High	0.35
All Time High Change	-98.57%
All Time High Date	2019-02-21
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2022-09-27
ATR	0
Beta	-0.5
Beta1y	-2.76
Beta2y	-1.69
Ch YTD	-50
High	0.01
High52	0.02
High52 Date	2024-11-26
High52ch	-75%
Low	0.01
Low52	0.01
Low52 Date	2025-09-05
Low52ch	0%
Ma50ch	-41.18%
Price vs 200-day SMA	-58.68%
RSI	42.87
RSI Monthly	36.18
RSI Weekly	42.74
Sharpe ratio	1.81x
Sortino ratio	3.43
Total Return	-129.87%
Tr YTD	-50
Tr1m	-50%
Tr3m	-50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.5M
Operating margin	-103.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	420,425
Shares Out	497,149,269
Shares Qo Q	2.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	231,457.7x
Bv Per Share	-0.01
Ch1m	-50
Ch1y	-66.67
Ch3m	-50
Ch3y	-50
Ch5y	-95
Ch6m	-50
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	30,401
Dollar Volume	2,240
Earnings Date	2026-07-10
EBIT	CAD -1.5M
EBITDA	CAD -1.5M
EPS	CAD -0.01
F Score	3
Financing CF	1,412,095
Fiscal Year End	April
Founded	2,011
Is Primary Listing	1
Last Earnings Date	2026-01-06
Last Report Date	2025-01-31
Ma150	0.01
Ma150ch	-56.9%
Ma20	0.01
Ma20ch	-26.47%
Net CF	-335,463
Next Earnings Date	2026-07-10
Open	0.01
Ppne	86,084
Price Date	2025-09-03
Relative Volume	1.94x
Revenue	1,472,906x
Tr6m	-50%
Volume	448,000
Z Score	-39.05

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/AION pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/AION stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

CSE/AION momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.9

Neutral momentum band

Price vs 200-day MA

-58.7%

50/200-day relationship not available

Beta (5Y)

-0.50

Less volatile than the market

Sharpe ratio

1.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/AION

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/AION stock rating?

cse/AION is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/AION analysis?

The full report lives at /stocks/cse/AION/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/AION?

The latest report frames cse/AION around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/AION page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.